NCT01626820View on ClinicalTrials.gov

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

113

Participants

Timeline

Start Date

July 19, 2012

Primary Completion Date

August 10, 2012

Study Completion Date

August 10, 2012

Conditions

Influenza

Interventions

BIOLOGICAL

Fluviral®

1 dose administered intramuscularly in deltoid region of non-dominant arm at Day 0

Trial Locations (1)

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01626820 - Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults | Biotech Hunter | Biotech Hunter